Home › Pneumococcal Infections
Pneumococcal Infections clinical trials recruiting in the U.S.
6 studies for Pneumococcal Infections are recruiting participants at sites across the United States.
Pneumococcal infections can be mild or severe. The most common types of infections are Meningitis, Sepsis, Pneumonia, and ear and sinus infections
Cities with the most studies
- Simpsonville, SC4 studies
- Syracuse, NY4 studies
- Tampa, FL4 studies
- Lincoln, NE3 studies
- Hialeah, FL3 studies
- Idaho Falls, ID3 studies
- Shreveport, LA3 studies
- Arlington, TX3 studies
- Miami, FL3 studies
- Cleveland, OH3 studies
- Sugar Land, TX3 studies
- Birmingham, AL3 studies
- League City, TX3 studies
- Ogden, UT3 studies
By state
- Alabama3 studies
- California4 studies
- Florida5 studies
- Idaho3 studies
- Kentucky4 studies
- Louisiana3 studies
- Michigan3 studies
- Nebraska3 studies
- New York5 studies
- Ohio3 studies
- South Carolina5 studies
- Texas5 studies
- Utah3 studies
- Virginia4 studies
Recently updated studies
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
RecruitingPhase 3Healthy volunteers welcome
42 Days – 98 Days · All sexes · Updated Nov 6, 2026 · NCT07573462Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
RecruitingPhase 3Healthy volunteers welcome
15 Months – 17 Years · All sexes · Updated Oct 26, 2026 · NCT07660198A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
RecruitingPhase 3Healthy volunteers welcome
42 Days – 211 Days · All sexes · Updated Oct 20, 2026 · NCT07629440Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
RecruitingPhase 3Healthy volunteers welcome
42 Days – 89 Days · All sexes · Updated Oct 5, 2026 · NCT07348692A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
RecruitingPhase 1Healthy volunteers welcome
2 Months – 15 Months · All sexes · Updated Oct 2, 2026 · NCT07300267Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07135453From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.